Edward Laane

1.5k total citations
27 papers, 754 citations indexed

About

Edward Laane is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Edward Laane has authored 27 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Hematology and 7 papers in Oncology. Recurrent topics in Edward Laane's work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Edward Laane is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Edward Laane collaborates with scholars based in Estonia, Sweden and United Kingdom. Edward Laane's co-authors include Dan Grandér, Theocharis Panaretakis, Katja Pokrovskaja Tamm, Boris Zhivotovsky, Mats Heyman, Joanna Mazur, Anna Porwit, Eva Buentke, Martin Corcoran and S Söderhäll and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Edward Laane

25 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Laane Estonia 14 378 182 182 133 116 27 754
Sean Garrison United States 10 595 1.6× 149 0.8× 86 0.5× 354 2.7× 44 0.4× 13 970
Tetsuya Kurosu Japan 18 473 1.3× 36 0.2× 327 1.8× 186 1.4× 179 1.5× 35 831
Donia M. Moujalled Australia 9 538 1.4× 54 0.3× 127 0.7× 73 0.5× 76 0.7× 17 689
Philip M. Hemken United States 10 745 2.0× 106 0.6× 47 0.3× 188 1.4× 42 0.4× 15 1.0k
Karoline Kollmann Austria 18 629 1.7× 47 0.3× 305 1.7× 413 3.1× 247 2.1× 31 1.2k
William H. Towns United States 12 325 0.9× 46 0.3× 62 0.3× 157 1.2× 218 1.9× 18 690
J A Truglia United States 13 406 1.1× 98 0.5× 75 0.4× 93 0.7× 23 0.2× 16 814
Cezary Swider United States 11 522 1.4× 61 0.3× 494 2.7× 239 1.8× 201 1.7× 20 1.1k
S. M. LUDEMAN United States 9 380 1.0× 27 0.1× 152 0.8× 275 2.1× 137 1.2× 12 730
Hendrik Nogai Germany 15 404 1.1× 50 0.3× 95 0.5× 340 2.6× 216 1.9× 35 1.0k

Countries citing papers authored by Edward Laane

Since Specialization
Citations

This map shows the geographic impact of Edward Laane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Laane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Laane more than expected).

Fields of papers citing papers by Edward Laane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Laane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Laane. The network helps show where Edward Laane may publish in the future.

Co-authorship network of co-authors of Edward Laane

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Laane. A scholar is included among the top collaborators of Edward Laane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Laane. Edward Laane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laane, Edward, et al.. (2025). MDS BIOLOGY AND PATHOGENESIS - CLONAL DIVERSITY & EVOLUTION. Leukemia Research. 156. 107853–107853.
2.
Olíva, Esther Natalie, Tatyana Ionova, Edward Laane, et al.. (2024). Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review. Frontiers in Oncology. 14. 1353101–1353101. 1 indexed citations
3.
Laane, Edward, Sam Salek, Esther Natalie Olíva, et al.. (2023). Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials. Cancers. 15(24). 5764–5764. 6 indexed citations
4.
Salek, Sam, Tatyana Ionova, Esther Natalie Olíva, et al.. (2022). The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. Cancers. 14(23). 6007–6007. 9 indexed citations
5.
Salek, Sam, Nina Kreuzberger, Vanessa Piechotta, et al.. (2021). Patient-reported outcomes in clinical trials for multiple myeloma: Where we are.. Journal of Clinical Oncology. 39(15_suppl). e18615–e18615. 2 indexed citations
6.
D’Sa, Shirley, Marie José Kersten, Jorge J. Castillo, et al.. (2017). Investigation and management of IgM and Waldenström‐associated peripheral neuropathies: recommendations from the IWWM ‐8 consensus panel. British Journal of Haematology. 176(5). 728–742. 47 indexed citations
7.
Tzogani, Kyriaki, Paula B. van Hennik, Jan Sjöberg, et al.. (2017). EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma. The Oncologist. 23(5). 631–636. 31 indexed citations
8.
Tzogani, Kyriaki, Alexandre Moreau, Pierre Démolis, et al.. (2017). The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy. The Oncologist. 22(11). 1339–1346. 10 indexed citations
9.
Hulegårdh, Erik, Erik Holmberg, Katrin Palk, et al.. (2016). Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years. Acta Haematologica. 136(3). 167–173.
10.
Laane, Edward, Subodh Kumar, Florence Magrangeas, et al.. (2015). XRCC5 Plays an Important Role in Homologous Recombination, Genome Stability and Survival of Myeloma Cells. Blood. 126(23). 1218–1218. 1 indexed citations
11.
12.
Kharaziha, Pedram, Hendrik De Raeve, Qiao Li, et al.. (2012). Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro , Ex Vivo , and In Vivo in the 5T33MM Mouse Model. Cancer Research. 72(20). 5348–5362. 42 indexed citations
13.
Buentke, Eva, Anna Nordström, Hui Lin, et al.. (2011). Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells. Blood Cancer Journal. 1(7). e31–e31. 30 indexed citations
14.
Grandér, Dan, Pedram Kharaziha, Edward Laane, Katja Pokrovskaja Tamm, & Theocharis Panaretakis. (2009). Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies. Autophagy. 5(8). 1198–1200. 54 indexed citations
15.
Laane, Edward, Katja Pokrovskaja Tamm, Eva Buentke, et al.. (2009). Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death and Differentiation. 16(7). 1018–1029. 176 indexed citations
16.
Laane, Edward, Theocharis Panaretakis, Katja Pokrovskaja Tamm, et al.. (2007). Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Haematologica. 92(11). 1460–1469. 49 indexed citations
17.
Laane, Edward, E. Björklund, Joanna Mazur, et al.. (2007). Dendritic Cell Regeneration in the Bone Marrow of Children Treated for Acute Lymphoblastic Leukaemia. Scandinavian Journal of Immunology. 66(5). 572–583. 12 indexed citations
18.
Laane, Edward, Åsa Rangert Derolf, Elisabet Björklund, et al.. (2006). The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.. PubMed. 91(6). 833–6. 42 indexed citations
19.
Panaretakis, Theocharis, Edward Laane, Katja Pokrovskaja Tamm, et al.. (2005). Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase Cδ, and c-Jun NH2-terminal Kinase to Induce Apoptosis. Molecular Biology of the Cell. 16(8). 3821–3831. 92 indexed citations
20.
Laane, Edward, Edneia Tani, Elisabet Björklund, et al.. (2005). Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Cytometry Part B Clinical Cytometry. 64B(1). 34–42. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sean Garrison Breakdown of academic impact, for papers by Tetsuya Kurosu Breakdown of academic impact, for papers by Donia M. Moujalled Breakdown of academic impact, for papers by Philip M. Hemken Breakdown of academic impact, for papers by Karoline Kollmann Breakdown of academic impact, for papers by William H. Towns Breakdown of academic impact, for papers by J A Truglia Breakdown of academic impact, for papers by Cezary Swider Breakdown of academic impact, for papers by S. M. LUDEMAN Breakdown of academic impact, for papers by Hendrik Nogai
Rankless by CCL
2026